NO20015510L - Medikament for lokal påföring - Google Patents

Medikament for lokal påföring

Info

Publication number
NO20015510L
NO20015510L NO20015510A NO20015510A NO20015510L NO 20015510 L NO20015510 L NO 20015510L NO 20015510 A NO20015510 A NO 20015510A NO 20015510 A NO20015510 A NO 20015510A NO 20015510 L NO20015510 L NO 20015510L
Authority
NO
Norway
Prior art keywords
medication
local application
local
application
Prior art date
Application number
NO20015510A
Other languages
English (en)
Other versions
NO20015510D0 (no
NO329232B1 (no
Inventor
Johann Eibl
Original Assignee
Bio & Bio Licensing Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio & Bio Licensing Sa filed Critical Bio & Bio Licensing Sa
Publication of NO20015510D0 publication Critical patent/NO20015510D0/no
Publication of NO20015510L publication Critical patent/NO20015510L/no
Publication of NO329232B1 publication Critical patent/NO329232B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/196Thrombopoietin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/363Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4833Thrombin (3.4.21.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/57Protease inhibitors from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20015510A 1999-05-19 2001-11-12 Medikament for lokal paforing og framgangsmate for framstilling av en fibrinogenholdig losning NO329232B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0089599A AT500670A1 (de) 1999-05-19 1999-05-19 Arzneimittel zur lokalen anwendung
PCT/AT2000/000141 WO2000071153A2 (de) 1999-05-19 2000-05-19 Arzneimittel zur lokalen anwendung, das fibrinogen, thrombin, transglutaminasen und proteinaseinhibitoren enthält

Publications (3)

Publication Number Publication Date
NO20015510D0 NO20015510D0 (no) 2001-11-12
NO20015510L true NO20015510L (no) 2001-11-12
NO329232B1 NO329232B1 (no) 2010-09-20

Family

ID=3502302

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015510A NO329232B1 (no) 1999-05-19 2001-11-12 Medikament for lokal paforing og framgangsmate for framstilling av en fibrinogenholdig losning

Country Status (14)

Country Link
US (1) US20020114796A1 (no)
EP (3) EP1632246A3 (no)
JP (1) JP2003500364A (no)
AT (1) AT500670A1 (no)
AU (1) AU5198600A (no)
CA (1) CA2372929C (no)
DE (1) DE50005999D1 (no)
DK (2) DK1183043T3 (no)
ES (2) ES2218167T3 (no)
HU (1) HU226016B1 (no)
MX (1) MXPA01011859A (no)
NO (1) NO329232B1 (no)
SK (1) SK16332001A3 (no)
WO (1) WO2000071153A2 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131933A1 (en) * 1996-01-16 2002-09-19 Yves Delmotte Biopolymer membrane and methods for its preparation
AT407484B (de) 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
AU2002213195A1 (en) * 2000-10-13 2002-04-22 Baxter Healthcare S.A. Reduction or prevention of post-surgical adhesion formation with fibrinogen
WO2002030445A2 (en) * 2000-10-13 2002-04-18 Baxter International Inc. Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation
DK1351697T3 (da) * 2001-01-18 2014-01-20 Georg Watzek Lægemiddel til fremme af regenerationen af væv
US8293530B2 (en) * 2006-10-17 2012-10-23 Carnegie Mellon University Method and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
US8529956B2 (en) 2002-03-18 2013-09-10 Carnell Therapeutics Corporation Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
EP1380290A1 (en) * 2002-07-09 2004-01-14 Universitair Medisch Centrum Utrecht Cross-beta structure pathway and its therapeutic relevance
US20070003552A1 (en) * 2002-07-09 2007-01-04 Gebbink Martijn F B Cross-beta structure comprising amyloid binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity and method for interfering with blood coagulation
GB0216002D0 (en) 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
US20090202980A1 (en) * 2005-03-21 2009-08-13 Crossbeta Biosciences B.V. Cross-Beta Structure Comprising Amyloid Binding Proteins and Methods for Detection of the Cross-Beta Structure, for Modulating Cross-Beta Structures Fibril Formation and for Modulating Cross-Beta Structure-Mediated Toxicity and Method for Interfering With Blood Coagulation
AU2006267177A1 (en) * 2005-07-13 2007-01-18 Crossbeta Biosciences B.V. Methods for determining the effect of a treatment on the cross-beta structure content of a protein; selection of treatments and uses thereof
US8114832B2 (en) * 2005-07-13 2012-02-14 Crossbeta Biosciences B.V. Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition
EP2386861A3 (en) 2005-07-13 2012-07-18 Crossbeta Biosciences B.V. Cross-ß structure binding compounds
US8529959B2 (en) 2006-10-17 2013-09-10 Carmell Therapeutics Corporation Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
EP2058000A1 (en) * 2007-11-08 2009-05-13 Crossbeta Biosciences B.V. Immunogenic compositions capable of activating T cells
HUE028626T2 (en) * 2008-06-23 2016-12-28 Bio-Products & Bio-Engineering Ag Stable, functionally intact, virus-inactivated fibrinogen during storage
JP6010460B2 (ja) * 2009-08-25 2016-10-19 セルビシオ アンダルス デ サルServicio Andaluz De Salud フィブリンおよびアガロース生体材料を用いる組織工学による、人工組織の製造
JP6875619B2 (ja) * 2015-02-26 2021-05-26 株式会社細胞応用技術研究所 多血小板血漿の保存方法
IL247821A0 (en) * 2016-09-14 2017-01-31 Omrix Biopharmaceuticals Ltd Adhesive preparations and their use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
ATE20824T1 (de) * 1981-06-25 1986-08-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung.
US4442655A (en) * 1981-06-25 1984-04-17 Serapharm Michael Stroetmann Fibrinogen-containing dry preparation, manufacture and use thereof
DE3622642A1 (de) * 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
SE9101853D0 (sv) * 1991-06-17 1991-06-17 Jonas Wadstroem Improved tissue ashesive
EP0534178B1 (en) * 1991-09-27 2001-04-18 Omrix Biopharmaceuticals S.A. Improved tissue glue prepared by using cryoprecipitate
EP0726956A1 (en) * 1991-12-31 1996-08-21 Zymogenetics, Inc. Novel human transglutaminases
US5254536A (en) * 1992-01-10 1993-10-19 The Du Pont Merck Pharmaceutical Company Therapeutic utility of plasminogen activator inhibitor-1 to control bleeding
JP3550685B2 (ja) * 1992-04-21 2004-08-04 味の素株式会社 創傷治療剤
JPH0654897A (ja) * 1992-08-08 1994-03-01 Chemo Sero Therapeut Res Inst フィブリノーゲン含有製剤
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
JP3620055B2 (ja) * 1994-01-31 2005-02-16 味の素株式会社 創傷治療剤
AT406120B (de) * 1997-08-28 2000-02-25 Immuno Ag Gewebekleber
AT407117B (de) * 1997-09-19 2000-12-27 Immuno Ag Fibrinschwamm

Also Published As

Publication number Publication date
CA2372929C (en) 2011-11-15
US20020114796A1 (en) 2002-08-22
AU5198600A (en) 2000-12-12
NO20015510D0 (no) 2001-11-12
HUP0200856A2 (hu) 2002-07-29
EP1632246A2 (de) 2006-03-08
WO2000071153A3 (de) 2001-04-26
EP1275397A2 (de) 2003-01-15
EP1632246A3 (de) 2009-03-11
SK16332001A3 (sk) 2002-05-09
DE50005999D1 (de) 2004-05-13
CA2372929A1 (en) 2000-11-30
JP2003500364A (ja) 2003-01-07
EP1183043A2 (de) 2002-03-06
ES2218167T3 (es) 2004-11-16
AT500670A1 (de) 2006-02-15
HUP0200856A3 (en) 2004-11-29
WO2000071153A2 (de) 2000-11-30
EP1275397A3 (de) 2003-07-02
DK1183043T3 (da) 2004-08-09
DK1275397T3 (da) 2014-09-22
NO329232B1 (no) 2010-09-20
EP1275397B1 (de) 2014-08-06
ES2499090T3 (es) 2014-09-26
MXPA01011859A (es) 2003-09-04
HU226016B1 (en) 2008-02-28
EP1183043B1 (de) 2004-04-07

Similar Documents

Publication Publication Date Title
NO20015175L (no) Farmasöytisk sammensetning
DE60044873D1 (de) Orientierte biopolymermembrane
DE60037203D1 (de) Medikamentenspender
DE60011853D1 (de) Injektionsspritze
DE122007000064I1 (de) Erythropoietinkonjugate
DE10084676T1 (de) Einmallanzettvorrichtung
ATA51899A (de) Handstempel
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
NO20015510D0 (no) Medikament for lokal påföring
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
IS2139B (is) Kvetíapínagnir
NO990431D0 (no) Golfk°llehode
PT1210085E (pt) Solucoes farmaceuticas de levosimendano
NO20022606D0 (no) Farmasöytiske kombinasjoner
NO20014926L (no) Farmasöytiske forbindelser
NO20020773D0 (no) Borkronekobling
DE50000805D1 (de) Aufsitzspanner
DE10085008T1 (de) Oberflächenbehandlungsdüse
FI4488U1 (fi) Farmaseuttinen koostumus
IS6163A (is) Lyfjakomplex
ATE269311T1 (de) Benzoylpyridazine
DE10082008D2 (de) Ausbeulgerät
ATE440824T1 (de) Nitro-sulfobenzamide
ATA107599A (de) Heizwasserbereiter
DE10085167T1 (de) Gangumschalteinrichtung

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BIO & BIO LICENSING SA, LU

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BIO PRODUCTS & BIO-ENGINEERING AKTIENGESELLS, AT

MM1K Lapsed by not paying the annual fees